| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Werewolf Therapeutics, Inc. | Director | Stock Option (right to buy) | 17.5K | May 24, 2024 | Direct | ||
| Oncorus, Inc. | Director | Stock Option (right to buy) | 12.5K | Jun 23, 2022 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| HOWL | Werewolf Therapeutics, Inc. | May 24, 2024 | 1 | $0 | 4 | May 24, 2024 | Director |
| HOWL | Werewolf Therapeutics, Inc. | Jun 21, 2023 | 1 | $0 | 4 | Jun 23, 2023 | Director |
| ONCR | Oncorus, Inc. | Jun 23, 2022 | 1 | $0 | 4 | Jun 24, 2022 | Director |
| HOWL | Werewolf Therapeutics, Inc. | Jun 1, 2022 | 1 | $0 | 4 | Jun 3, 2022 | Director |
| ONCR | Oncorus, Inc. | Jun 16, 2021 | 1 | $0 | 4 | Jun 17, 2021 | Director, 10%+ Owner |